-
2025-10-10 16:00
Completed Enrollment in First-In-Human Phase I study of Less Invasive ApproachExpected to Present 6-Month data in 2026 at a major Cardiology CongressVia Less Invasive Approach, more Cardiologists could implant out-patientAdditional studies expanding indications and level of evide
-
2025-10-09 00:19
-
2025-10-07 23:00
-
2025-10-06 12:00
TOKYO, Oct. 7, 2025 /PRNewswire/ -- As a leading global provider of real-time communications technology and IP optical networking solutions, maintaining and optimizing networks of many of the world's largest service providers and critical infrastructure operators, Ribbon Communic
-
2025-10-06 16:00
-
2025-10-05 00:50
-
2025-10-04 00:57
-
2025-10-03 19:58
-
2025-10-02 16:00
-
2025-10-02 15:13
BOSTON, Oct. 2, 2025 /PRNewswire/ --Addressing Critical Unmet Medical NeedExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. Current Alzheimer's ther